These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 16514715)

  • 21. Bronchoscopy for bevacizumab-related hemoptysis.
    Cho YJ; Murgu SD; Colt HG
    Lung Cancer; 2007 Jun; 56(3):465-8. PubMed ID: 17368626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bevacizumab-based therapy for advanced small bowel adenocarcinoma.
    Tsang H; Yau T; Khong PL; Epstein RJ
    Gut; 2008 Nov; 57(11):1631-2. PubMed ID: 18941013
    [No Abstract]   [Full Text] [Related]  

  • 23. Case of anterior uveitis after intravitreal injection of bevacizumab.
    Pieramici DJ; Avery RL; Castellarin AA; Nasir MA; Rabena M
    Retina; 2006 Sep; 26(7):841-2. PubMed ID: 16963867
    [No Abstract]   [Full Text] [Related]  

  • 24. Glomerular disease related to anti-VEGF therapy.
    Stokes MB; Erazo MC; D'Agati VD
    Kidney Int; 2008 Dec; 74(11):1487-91. PubMed ID: 18547991
    [No Abstract]   [Full Text] [Related]  

  • 25. High incidence of fistula formation during bevacizumab treatment in rectal cancer patients.
    Wolf I; Urban D; Pfeffer R; Catane R; Aderka D
    Acta Oncol; 2007; 46(4):550-3. PubMed ID: 17497324
    [No Abstract]   [Full Text] [Related]  

  • 26. Bevacizumab for corneal neovascularization.
    Jacobs DS; Lim M; Carrasquillo KG; Rosenthal P
    Ophthalmology; 2009 Mar; 116(3):592-3; author reply 593-4. PubMed ID: 19264217
    [No Abstract]   [Full Text] [Related]  

  • 27. Reversible posterior leukoencephalopathy syndrome caused by bevacizumab: report of a case.
    Koopman M; Muller EW; Punt CJ
    Dis Colon Rectum; 2008 Sep; 51(9):1425-6. PubMed ID: 18470563
    [No Abstract]   [Full Text] [Related]  

  • 28. Bevacizumab local complications.
    Gordon-Angelozzi M; Velez-Montoya R; Fromow-Guerra J; García-Aguirre G; Guerrero-Naranjo JL; Quiroz-Mercado H; Morales-Cantón V
    Ophthalmology; 2009 Nov; 116(11):2264.e1-3. PubMed ID: 19883862
    [No Abstract]   [Full Text] [Related]  

  • 29. Reversible posterior leukoencephalopathy syndrome complicating cytotoxic chemotherapy for hematologic malignancies.
    Tam CS; Galanos J; Seymour JF; Pitman AG; Stark RJ; Prince HM
    Am J Hematol; 2004 Sep; 77(1):72-6. PubMed ID: 15307110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A prospective study of blood pressure and intraocular pressure changes in hypertensive and nonhypertensive patients after intravitreal bevacizumab injection.
    Lee K; Yang H; Lim H; Lew HM
    Retina; 2009; 29(10):1409-17. PubMed ID: 19816242
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bevacizumab in the treatment of breast cancer.
    Koutras AK; Fountzilas G; Makatsoris T; Peroukides S; Kalofonos HP
    Cancer Treat Rev; 2010 Feb; 36(1):75-82. PubMed ID: 19932567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple cutaneous ecchymoses associated with the administration of bevacizumab.
    Trafalis DT; Grivas AA; Athanassiou AE
    J BUON; 2008; 13(4):575-6. PubMed ID: 19145684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute aortic dissection in a hypertensive patient with prostate cancer undergoing chemotherapy containing bevacizumab.
    Aragon-Ching JB; Ning YM; Dahut WL
    Acta Oncol; 2008; 47(8):1600-1. PubMed ID: 18607842
    [No Abstract]   [Full Text] [Related]  

  • 34. Gene expression of vascular endothelial growth factor A, thymidylate synthase, and tissue inhibitor of metalloproteinase 3 in prediction of response to bevacizumab treatment in colorectal cancer patients.
    Watanabe T; Kobunai T; Yamamoto Y; Matsuda K; Ishihara S; Nozawa K; Iinuma H; Ikeuchi H
    Dis Colon Rectum; 2011 Aug; 54(8):1026-35. PubMed ID: 21730794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early loss of pregnancy after intravitreal bevacizumab injection.
    Petrou P; Georgalas I; Giavaras G; Anastasiou E; Ntana Z; Petrou C
    Acta Ophthalmol; 2010 Jun; 88(4):e136. PubMed ID: 19740128
    [No Abstract]   [Full Text] [Related]  

  • 36. [Bevacizumab-induced abdominal aortic thrombosis].
    Védrine L; Chargari C
    Presse Med; 2008 Dec; 37(12):1829-30. PubMed ID: 18829251
    [No Abstract]   [Full Text] [Related]  

  • 37. Sixth nerve palsy post intravitreal bevacizumab for AMD: a new possibly causal relationship and complication?
    Park HJ; Guy J
    Binocul Vis Strabismus Q; 2007; 22(4):209. PubMed ID: 18163895
    [No Abstract]   [Full Text] [Related]  

  • 38. Anti-vascular endothelial growth factor monoclonals in non-small cell lung cancer.
    Sandler AB; Johnson DH; Herbst RS
    Clin Cancer Res; 2004 Jun; 10(12 Pt 2):4258s-4262s. PubMed ID: 15217970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiographic changes after bevacizumab.
    Ikuno Y; Soga K; Wakabayashi T; Gomi F
    Ophthalmology; 2009 Nov; 116(11):2263.e1. PubMed ID: 19883861
    [No Abstract]   [Full Text] [Related]  

  • 40. [Posterior reversible leukoencephalopathy syndrome caused by cisplatin: a case report].
    Romano LM; de Robles P; Ioli P; García-Saiz E
    Rev Neurol; 2005 Nov 1-15; 41(9):573-4. PubMed ID: 16254865
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.